Positive feedback between PU.1 and the cell cycle controls myeloid differentiation

Science

Volumn 341, Issue 6146, 2013, Pages 670-673

  Kueh, Hao Yuan ^a   Champhekhar, Ameya ^a   Nutt, Stephen L ^b   Elowitz, Michael B ^a,c   Rothenberg, Ellen V ^a  

^a CALIFORNIA INSTITUTE OF TECHNOLOGY   (United States)

^b WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH   (Australia)

^c California Institute of Technology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD11B ANTIGEN; CYCLIN D2; CYCLIN DEPENDENT KINASE INHIBITOR 1A; MYC PROTEIN; PROTEIN MYB; TRANSCRIPTION FACTOR PU 1;

CYTOLOGY; FUNCTIONAL ROLE; GENE EXPRESSION; NUMERICAL MODEL; PHYSIOLOGY; PROTEIN;

ARTICLE; AUTOREGULATION; BONE MARROW CELL; CELL CYCLE REGULATION; CELL DIFFERENTIATION; CELL FATE; FLOW CYTOMETRY; G1 PHASE CELL CYCLE CHECKPOINT; MACROPHAGE; MATHEMATICAL MODEL; MYELOID PROGENITOR CELL; NONHUMAN; POSITIVE FEEDBACK; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATOR GENE; UPREGULATION;

EID: 84881236410     PISSN: 00368075     EISSN: 10959203     Source Type: Journal    
DOI: 10.1126/science.1240831     Document Type: Article

References (34)

1. H. Singh, R. P. DeKoter, J. C. Walsh, Cold Spring Harb. Symp. Quant. Biol. 64, 13-20 (1999).
2. S. L. Nutt, D. Metcalf, A. D'Amico, M. Polli, L. Wu, J. Exp. Med. 201, 221-231 (2005).
3. J. Back, D. Allman, S. Chan, P. Kastner, Exp. Hematol. 33, 395-402 (2005).
4. Y. Arinobu et al., Cell Stem Cell 1, 416-427 (2007).
5. R. P. DeKoter, H. Singh, Science 288, 1439-1441 (2000).
6. M. K. Anderson, A. H. Weiss, G. Hernandez-Hoyos, C. J. Dionne, E. V. Rothenberg, Immunity 16, 285-296 (2002).
7. C. J. Spooner, J. X. Cheng, E. Pujadas, P. Laslo, H. Singh, Immunity 31, 576-586 (2009).
8. S. Carotta et al., Immunity 32, 628-641 (2010).
9. F. Rosenbauer, D. G. Tenen, Nat. Rev. Immunol. 7, 105-117 (2007).
10. Y. Okuno et al., Mol. Cell. Biol. 25, 2832-2845 (2005).
11. M. A. Zarnegar, J. Chen, E. V. Rothenberg, Mol. Cell. Biol. 30, 4922-4939 (2010).
12. M. Leddin et al., Blood 117, 2827-2838 (2011).
13. P. B. Staber et al., Mol. Cell 49, 934-946 (2013).
14. A. B. Cantor, S. H. Orkin, Oncogene 21, 3368-3376 (2002).
15. K. S. Choe, O. Ujhelly, S. N. Wontakal, A. I. Skoultchi, J. Biol. Chem. 285, 3044-3052 (2010).
16. W. D. Cook et al., Blood 104, 3437-3444 (2004).
17. F. Rosenbauer et al., Nat. Genet. 36, 624-630 (2004).
18. M. J. Walter et al., Proc. Natl. Acad. Sci. U.S.A. 102, 12513-12518 (2005).
19. D. Metcalf et al., Proc. Natl. Acad. Sci. U.S.A. 103, 1486-1491 (2006).
20. M. D. Delgado et al., Biochem. Biophys. Res. Commun. 252, 383-391 (1998).
21. R. P. DeKoter, J. C. Walsh, H. Singh, EMBO J. 17, 4456-4468 (1998).
22. Materials and methods are available as supplementary materials on Science Online.
23. E. Eden et al., Science 331, 764-768 (2011).
24. B. Schwanhäusser et al., Nature 473, 337-342 (2011).
25. P. L. Toogood et al., J. Med. Chem. 48, 2388-2406 (2005).
26. F. Kihara-Negishi et al., Int. J. Cancer 76, 523-530 (1998).
27. T. Bellon, D. Perrotti, B. Calabretta, Blood 90, 1828-1839 (1997).
28. C. B. Franco et al., Proc. Natl. Acad. Sci. U.S.A. 103, 11993-11998 (2006).
29. C. Tan, P. Marguet, L. You, Nat. Chem. Biol. 5, 842-848 (2009).
30. L. A. Buttitta, B. A. Edgar, Curr. Opin. Cell Biol. 19, 697-704 (2007).
31. R. A. Steinman, Oncogene 21, 3403-3413 (2002).
32. P. Salomoni, F. Calegari, Trends Cell Biol. 20, 233-243 (2010).
33. R. Dahl et al., Nat. Immunol. 4, 1029-1036 (2003).
34. A. K. Trivedi et al., Oncogene 26, 1789-1801 (2007).